about
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic diseaseCold hypersensitivity increases with age in mice with sickle cell diseasePlacenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD).A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis.Avascular Necrosis of the Hip in Sickle Cell Disease in Oman: Is it serious enough to warrant bone marrow transplantation?Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells.Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S.Pediatric stroke: clinical findings and radiological approachA rapid paper-based test for quantifying sickle hemoglobin in blood samples from patients with sickle cell disease.Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.Redox-dependent impairment of vascular function in sickle cell disease.Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell diseaseIntravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors.Cerebrovascular disease associated with sickle cell pulmonary hypertension.Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy.Coagulation activation in sickle cell trait: an exploratory studyCentral nervous system complications of sickle cell disease in children: an overview.Cysteine-iron promotes arginase activity by driving the Fenton reaction.Original Research: Sickle cell anemia and pediatric strokes: Computational fluid dynamics analysis in the middle cerebral artery.Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment.Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia.Interplay between coagulation and vascular inflammation in sickle cell disease.Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell diseaseIn vitro evidence of the inhibitory capacity of chloroquine on arginase activity in sickle erythrocytes.Brain neurochemical and hemodynamic findings in the NY1DD mouse model of mild sickle cell disease.The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease.Placenta growth factor mediated gene regulation in sickle cell disease.Higher prevalence of spontaneous cerebral vasculopathy and cerebral infarcts in a mouse model of sickle cell disease.
P2860
Q26999284-BCD74D8E-CDD5-4997-938B-F6DEF425CE48Q27304663-E55C5CFC-C366-4834-BC41-E0D3629AE701Q33883207-EAA8B693-4241-4824-8EDE-8BBC8F59FD0AQ34038874-C39D79D4-7083-425A-93C3-FCB834DA97D6Q34782300-4BEDC4C0-B0CB-4556-9FA5-B187F6406E22Q34806514-204C4E4C-1570-424D-9594-98E99D3AF428Q34924453-853E9937-4C7C-465D-8264-D32E06F78595Q34985308-74334A5E-3E3E-4E5F-A9B3-09CC4BB8AF92Q35630272-A165DCEB-2551-4157-9CB5-99E5376DC00CQ35881838-F0ABABEF-12D2-40A2-BF39-2783E34477DCQ36274222-BA3022B7-2D14-4F50-A5C9-A9BD05DB0F44Q36353647-D8113458-A5CA-4EF8-8D4C-634C9B40255FQ36384725-4B2A2993-F779-47EB-A067-5151A85E672AQ36391734-50A69692-532F-45F5-9B1B-238AADF6DF4EQ36392798-30A21626-542F-40FD-A578-0745E1B05827Q36434471-D531428A-2FBB-4170-A1FE-6FEA3D9DF4CCQ36661960-5614973E-3523-4846-909E-F0EC80C6E5FBQ36761420-A64D9ED2-2BFD-42BA-806A-DEC03AAA5415Q36979880-0F2123E7-9F42-4934-A0B6-D4D90E703CF4Q37107179-C5ACB97E-7E9C-472F-B460-C68BC533B34AQ37159329-E0A95F76-211B-4E4C-8050-59B1146A697EQ38089946-51A610B8-B64F-4977-B727-32ED260FB942Q38099667-EFDD4588-BB21-49DE-AAD5-581BCC3FB6E3Q41900907-807F0004-30F0-486D-932F-22B5D3D39444Q41942150-332466A0-6905-4869-9D1C-5F05D67115AEQ42505511-F952B237-D36E-4E26-ADE8-A17A3D2F0610Q43598789-A5466B86-7C25-4F7D-A055-2EF93741AA04Q46063095-ED3CAB34-78CB-4562-B659-E507C1FB631BQ47660286-3AE9186D-439F-4C17-BD73-BFA126B5AB54
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pathophysiology of stroke in sickle cell disease.
@ast
Pathophysiology of stroke in sickle cell disease.
@en
type
label
Pathophysiology of stroke in sickle cell disease.
@ast
Pathophysiology of stroke in sickle cell disease.
@en
prefLabel
Pathophysiology of stroke in sickle cell disease.
@ast
Pathophysiology of stroke in sickle cell disease.
@en
P1433
P1476
Pathophysiology of stroke in sickle cell disease.
@en
P2093
Cheryl A Hillery
Julie A Panepinto
P304
P356
10.1080/10739680490278600
P577
2004-03-01T00:00:00Z